Amgen (AMGN) Tops Q4 EPS by 27c, Beats on Revenue; Offers FY25 EPS Guidance
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $374.15 --0%
Revenue Growth %: +2.6%
Financial Fact:
Product sales: 5.52B
Today's EPS Names:
CRMT, PKE, More
Revenue Growth %: +2.6%
Financial Fact:
Product sales: 5.52B
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q4 EPS of $5.31, $0.27 better than the analyst estimate of $5.04. Revenue for the quarter came in at $9.1 billion versus the consensus estimate of $8.85 billion.
GUIDANCE:
Amgen sees FY2025 EPS of $20.00-$21.20, versus the consensus of $20.82.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meritage Homes (MTH) Reiterated at Market Outperform by Citizens: Stock up 24%
- Provenance Gold Intersects 1.82 g/t Gold over 116.74m Including 8.31 g/t Gold over 12.34m at Eldorado West
- LGI Homes (LGIH) Reiterated at Market Outperform by Citizens: Stock up 44%
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
